Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Moonlake Immunotherapeutics (MLTX) Reiterated at Overweight by Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Moonlake Immunotherapeutics (MLTX)
-
Acelyrin (SLRN) crashes 60% as lead product misses in study; Seen as a 'big positive' for MoonLake (MLTX)
-
MoonLake Immunotherapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update
-
MoonLake Immunotherapeutics (MLTX) Prices 8M Share Offering at $50/sh
-
MoonLake Immunotherapeutics Announces Pricing of $400 Million Upsized Public Offering of Class A Ordinary Shares
-
MoonLake Immunotherapeutics (MLTX) Announces Proposed Underwritten Public Offering
-
MoonLake Immunotherapeutics Announces Proposed Underwritten Public Offering
-
MoonLake jumps 100% on impressive Phase 2 MIRA trial results, analysts react
